← All trials
NCT05011357
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 10, 2021
- Primary completion
- Dec 30, 2021
- Completion date
- Jun 30, 2022
- First posted
- Aug 18, 2021
- Last posted
- Oct 28, 2021
- Enrollment
- 6
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The University of Texas, DallasLead sponsor
- The University of Texas, DallasReponsible party - principal investigator
- The University of Texas, DallasOverall official - principal investigator
- Texas Health ResourcesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.